Diana M. Lopez

Affiliations: 
University of Miami, Coral Gables, FL 
Area:
Immunology, Microbiology Biology
Google:
"Diana Lopez"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Castillo-Rivera F, Ondo-Méndez A, Guglielmi J, et al. (2020) Tumor microenvironment affects exogenous sodium/iodide symporter expression. Translational Oncology. 14: 100937
Hao M, Luque-Fernandez MA, Lopez D, et al. (2019) Benign Adrenocortical Tumors and the Detection of Nonadrenal Neoplasia. International Journal of Endocrinology. 2019: 9035407
Miska J, Lui JB, Toomer KH, et al. (2018) Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines. The Journal of Experimental Medicine
Lamas A, Lopez E, Carrio R, et al. (2015) Adipocyte and leptin accumulation in tumor-induced thymic involution. International Journal of Molecular Medicine
Ilkovitch D, Carrio R, Lopez DM. (2013) Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1. Immunologic Research. 57: 70-80
Carrio R, Lopez DM. (2013) Insights into thymic involution in tumor-bearing mice. Immunologic Research. 57: 106-14
Carrio-Jardines R, Iragavarapu-Charyulu V, Libreros S, et al. (2013) Abstract 448: Mechanisms involved in the tumor-induced thymic involution. Cancer Research. 73: 448-448
Ilkovitch D, Carrio R, Lopez DM. (2012) uPA and uPA-receptor are involved in cancer-associated myeloid-derived suppressor cell accumulation. Anticancer Research. 32: 4263-70
Carrio R, Torroella-Kouri M, Libreros S, et al. (2011) Decreased accumulation of immune regulatory cells is correlated to the antitumor effect of IFN-γ overexpression in the tumor. International Journal of Oncology. 39: 1619-27
Carrio R, Torroella-Kouri M, Iragavarapu-Charyulu V, et al. (2011) Tumor-induced thymic atrophy: alteration in interferons and Jak/Stats signaling pathways. International Journal of Oncology. 38: 547-53
See more...